Bottom line
MIPXX vs HFXI: the short answer
MIPXX (NYLI Money Market Fund) and HFXI (NYLI FTSE International Equity Currency Neutral ETF) are both money market funds.
HFXI is cheaper at 0.2% vs 0.47% — a difference of $27 a year per $10,000 invested.
Over five years, HFXI returned +11.2% a year vs +2.9% for MIPXX.
Updated Nov 19, 2026
MIPXX vs HFXI side by side
| MIPXX | HFXI | |
|---|---|---|
| Type | Money market fund | ETF |
| Fund family | MFS | New York Life Investments |
| Category | Money Market | International Stock |
| Expense ratio | 0.47% | 0.2% |
| Annual cost per $10k | $47 | $20 |
| 10-yr cost on $10k (prospectus) | $591 | $255 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.9% | +30.1% |
| 5-yr return (annualized) | +2.9% | +11.2% |
| 10-yr return (annualized) | +2.7% | +9.5% |
| Best quarter | — | +15.0% |
| Worst quarter | — | −21.3% |
| Net assets (fund) | — | $2.0B |
| Number of holdings | — | 930 |
| Portfolio turnover | — | 14% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MIPXX and HFXI share none of their top holdings.
MIPXX top 10
HFXI top 10
- Samsung Electronics Co Ltd — 3.70%
- Sk Hynix Inc — 2.61%
- Asml Holding Nv — 2.43%
- Hsbc Holdings Plc — 1.38%
- Roche Holding Ag — 1.22%
- Novartis Ag — 1.12%
- Shell Plc — 0.98%
- Nestle' Sa/ag — 0.98%
- Astrazeneca Plc — 0.97%
- Mitsubishi Ufj Financial Group Inc — 0.96%
FAQ
What is the difference between MIPXX and HFXI?
MIPXX (NYLI Money Market Fund) and HFXI (NYLI FTSE International Equity Currency Neutral ETF) are both money market funds. HFXI is cheaper at 0.2% vs 0.47% — a difference of $27 a year per $10,000 invested.
Which is cheaper, MIPXX or HFXI?
HFXI has the lower expense ratio (0.2%).
Should I own both MIPXX and HFXI?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.